Mallinckrodt Judge Asks Whether Opioid Legal Shield Is Fair
- Drug maker seeks legal protections rejected in Purdue case
- Judge didn’t say how he would rule on bankruptcy exit plan
This article is for subscribers only.
The judge overseeing the reorganization of opioid maker Mallinckrodt Plc questioned the fairness of a plan to protect executives and others from future lawsuits, echoing the dispute that upended Purdue Pharma’s effort to settle its own highly charged opioid bankruptcy case.
Under Mallinckrodt’s $5.45 billion settlement plan, officers and directors could not be sued in most cases for their alleged role in America’s opioid epidemic. During a virtual court hearing on the proposal Thursday, U.S. Bankruptcy Judge John Dorsey asked how the legal protections would affect creditors who may want to keep suing Mallinckrodt.